Antero Midstream reports Q2 results today, and the data already tells a story the insiders scripted months ago.
The insider selling overhang that defined the pre-earnings setup has now resolved into something cleaner: the executives who sold were right. CEO Michael Kennedy exited $2.2 million worth of shares in early May at $21.92. His March cluster added $2.5 million more, at prices between $22 and $23. The CFO and Chief Compliance Officer layered in alongside, pushing aggregate 90-day net selling past $15 million. The stock closed Tuesday at $21.52 — below every one of those exit prices. The month's 7.2% decline and a 5.8% weekly slide have handed the sellers a clear short-term vindication, with the share price now sitting beneath the entire recorded transaction range.
The positioning data shifted abruptly in the final session before the print. Short interest jumped 13.6% in a single day on July 28, pushing the estimated figure to 2.34% of the free float — up roughly 8% on the week, after a month of gradual declines. That single-session move is the sharpest in the 30-day window and suggests at least some traders positioned for a weak number. The borrow market qualifies that read sharply, however: availability remains extraordinarily loose at 1,829%, meaning there is no meaningful squeeze risk and the marginal cost to borrow stays negligible at 0.46%. The short interest spike looks opportunistic rather than structural.
Options tell a different story from the late short-selling. The put/call ratio edged up to 0.24 — slightly above its 20-day average of 0.22 and about one standard deviation above the recent mean — but remains close to the 52-week floor of 0.19. The broader options skew still leans toward calls, not protection. That mild divergence between the options market and the day-before short-interest jump is the tension the Q2 numbers will resolve: either the call-heavy positioning was the smarter read, or the insiders and the last-minute shorts had it right all along.
The analyst community has been quietly lifting targets throughout 2026 — UBS moved to $24 in March, Goldman went to $23 in February — yet the consensus price target of $24.14 now implies roughly 12% upside from current levels, a gap that has widened as the stock has slipped. The forward earnings yield has improved as a result, and the 12-month EPS momentum factor ranks in the 99th percentile of the ORTEX universe, suggesting estimates have been moving in the right direction. The question the print answers is whether those improving estimates reflect real operational momentum or a consensus that has simply been chasing a rising gas price environment that may not persist at current Appalachian throughput levels.
See the live data behind this article on ORTEX.
Open AM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
